NAP1L1 and pancreatic neuroendocrine neoplasm: NAP1L1 has been shown as a potential tumor promoter and participates in the pathogenesis of several tumors including colorectal cancer, renal cancer, and pancreatic neuroendocrine neoplasm (Schimmack et al., 2014; Zhai et al., 2018; Queiroz et al., 2020).